Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Description:** 2-deoxy-2-fluoro-beta-D-mannose is a synthetic monosaccharide derivative of mannose in which the hydroxyl group at the C‑2 position is replaced by a fluorine atom. It belongs to the class of hexoses and is structurally related to beta-D-mannopyranose[1][2][3]. This compound is primarily used as a research tool in glycobiology and carbohydrate metabolism studies. Its unique fluorine substitution makes it valuable for investigating glycan structure-function relationships and for use as a building block in drug discovery and glycomimetics[5]. Derivatives such as radiolabeled forms (e.g., ^18F-FDM) are being explored for diagnostic imaging applications like PET tumor imaging due to their altered metabolic properties compared to natural sugars[8]. The mechanism of action depends on its application; generally, it acts as an analog or probe rather than exerting direct pharmacological effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 2-deoxy-2-fluoro-β-D-mannose.